Armistice Capital, LLC Charles River Laboratories International, Inc. Transaction History

Armistice Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$206.39 - $268.73 $10.2 Million - $13.2 Million	49,189 Added 70.39%	119,071 $24.6 Million
Q1 2024 May 15, 2024	BUY	$203.52 - $273.43 $6.9 Million - $9.26 Million	33,882 Added 94.12%	69,882 $18.9 Million
Q4 2023 Feb 13, 2024	SELL	$164.52 - $238.84 $19.7 Million - $28.7 Million	-120,000 Reduced 76.92%	36,000 $8.51 Million
Q3 2023 Nov 14, 2023	BUY	$194.44 - $217.61 $30.3 Million - $33.9 Million	156,000 New	156,000 $30.6 Million

695

52.2M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.64B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Armistice Capital, LLC with notifications on news.